| [1] |
Grimm MO, Hundsdorfer B, Grosgen S, et al. dependent app cleavage regulates glucosylceramide synthase and is affected in alzheimer′s disease[J]. Cell Physiol Biochem, 2014, 34(1): 92-110.
|
| [2] |
Peng D, Pan X, Cui J, et al. Hyperphosphorylation of tau protein in hippocampus of central insulin-resistant rats is associated with cognitive impairment[J]. Cell Physiol Biochem，2013, 32(5): 1417-1425.
|
| [3] |
Ballard C, Gauthier S, Corbett A, et al. Alzheimer′s disease[J]. Lancet, 2011，377(9770)：1019-1031.
|
| [4] |
Colpo GD, Ascoli BM, Wollenhaupt-Aguiar B，et al. Mesenchymal stem cells for the treatment of neurodegenerative and psychiatric disorders[J]. An Acad Bras Cienc，2015，87(2 Suppl)：1435-1449.
|
| [5] |
Rossignol J, Fink KD, Crane AT, et al. Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington′s disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number[J]. Stem Cell Res Ther, 2015，6：9.
|
| [6] |
Lochhead JJ, Thorne RG.Intranasal delivery of biologics to the central nervous system[J]. Adv Drug Deliv Rev, 2012，64(7)：614-628.
|
| [7] |
Danielyan L, Beer-Hammer S, Stolzing A, et al. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer′s and Parkinson′s disease[J]. Cell Transplant, 2014，23 (Suppl 1)：S123-S139.
|
| [8] |
Walczak P, Zhang J, Gilad AA，et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia[J]. Stroke, 2008 ，39(5)：1569-1574.
|
| [9] |
Lee JS, Hong JM, Moon GJ, et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke[J]. Stem Cells, 2010，28(6)：1099-1106.
|
| [10] |
Li WY, Jin RL, Hu XY. Migration of PKH26-labeled mesenchymal stem cells in rats with Alzheimer′s disease[J]. Zhejiang Da Xue Xue Bao Yi Xue Ban, 2012，41(6)：659-664.
|
| [11] |
Song MS, Learman CR, Ahn KC, et al. In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice[J]. Neuroscience, 2015，307：37-50.
|
| [12] |
Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains [J] . Proc Natl Acad Sci USA, 1999, 96 (19)：10711-10716.
|
| [13] |
Deng W, Obrocka M, Fischer I, et al. In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP[J]. Biochem Biophys Res Commun, 2001, 282(1) : 148-152.
|
| [14] |
Joe IS, Jeong SG, Cho GW. Resveratrol-induced SIRT1 activation promotes neuronal differentiation of human bone marrow mesenchymal stem cells[J]. Neurosci Lett, 2015，584：97-102.
|
| [15] |
Joe IS, Cho GW.PDE4 Inhibition by Rolipram Promotes Neuronal Differentiation in Human Bone Marrow Mesenchymal Stem[J]. Cell Reprogram, 2016，18(4)：224-229.
|
| [16] |
Yu J, Liu XL, Cheng QG, et al. G-CSF and hypoxic conditioning improve the proliferation, neural differentiation and migration of canine bone marrow mesenchymal stem cells[J]. Exp Ther Med, 2016，12(3)：1822-1828.
|
| [17] |
Lee JK, Jin HK, Endo S，et al.Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer′s disease mice by modulation of immune responses[J]. Stem Cells, 2010，28(2)：329-343.
|
| [18] |
Babaei P, Soltani Tehrani B, Alizadeh A．Transplanted bone marrow mesenchymal stem cells improve memory in rat models of Alzheimer′s disease[J]. Stem Cells Int, 2012，2012：369417.
|
| [19] |
Kim JY, Kim DH, Kim JH, et al.Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-beta plaques[J]. Cell Death Differ，2012, 19(4): 680-691.
|
| [20] |
Bae JS, Jin HK, Lee JK, et al. Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-β deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer′s disease[J]. Curr Alzheimer Res, 2013，10(5)：524-531.
|
| [21] |
Naaldijk Y, Jäger C, Fabian C, et al. Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP/PS1 Alzheimer mice[J]. Neuropathol Appl Neurobiol, 2016，[Epub ahead of print].
|
| [22] |
Liu Z, Wang C, Wang X, et al.Therapeutic Effects of Transplantation of As-MiR-937-Expressing Mesenchymal Stem Cells in Murine Model of Alzheimer′s Disease [J]. Cell Physiol Biochem, 2015，37(1)：321-330.
|
| [23] |
Zhang X, Zhang L, Cheng X, et al. Igf-1 promotes brn-4 expression and neuronal differentiation of neural stem cells via the pi3k/akt pathway[J]. PLoS One, 2014，9(12)：e113801.
|
| [24] |
Malm TM, Koistinaho M, Pärepalo M，et al.Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice[J]. Neurobiol Dis, 2005，18(1)：134-142.
|
| [25] |
Yang MS, Ji KA, Jeon SB, et al. Interleukin-13 enhances cyclooxygenase-2 expression in activated rat brain microglia: implications for death of activated microglia[J]．J Immunol，2006，177(2): 1323-1329.
|
| [26] |
Mo SJ, Zhong Q, Zhou YF, et al. Bone marrow-derived mesenchymal stem cells prevent the apoptosis of neuron-like PC12 cells via erythropoietin expression[J]. Neurosci Lett, 2012，522(2)：92-97.
|
| [27] |
Tang Y, Cui Y, Luo F, et al. Cell viability and dopamine secretion of 6-hydroxydopamine-treated PC12 cells co-cultured with bone marrow-derived mesenchymal stem cells[J]. Neural Regen Res, 2012，7(14)：1101-1105.
|
| [28] |
Hokari M, Kuroda S, Shichinohe H, et al. Bone marrow stromal cells protect and repair damaged neurons through multiple mechanisms[J]. J Neurosci Res, 2008 ，86(5)：1024-1035.
|
| [29] |
Wollen KA. Alzheimer′s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners[J]. Altern Med Rev, 2010，15(3)：223-244.
|
| [30] |
Zhang YZ, Lou JY, Bai HY, et al. Protective effect of bone marrow mesenchymal stem cells on PC12 cells apoptosis mediated by TAG1[J]. Int J Clin Exp Pathol, 2015，8(10)：12093-12100.
|
| [31] |
Grimm MO, Mett J, Stahlmann CP, et al. APP intracellular domain derived from amyloidogenic beta-and gamma-secretase cleavage regulates neprilysin expression[J]. Front Aging Neurosci, 2015，7：77.
|
| [32] |
Nagase H, Nakayama K. The Intracellular Domain of Amyloid Precursor Protein is a Potential Therapeutic Target in Alzheimer′s Disease[J]. Curr Drug Discov Technol, 2014，11(4)：243-258.
|
| [33] |
Chen TS, Lai RC, Lee MM，et a1.Mesenchymal stem cell secretes micropartieles enriched in pre-microRNAs[J]. Nucleic Acids Res，2010，38(1)：215-224.
|
| [34] |
Lopez-Verrilli MA, Caviedes A, Cabrera A, et a1. Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic out growth[J]. Neuroscience, 2016 ，320：129-139.
|
| [35] |
冯影，卢士红，王昕，等，人骨髓来源间充质干细胞分泌外泌体特性研究[J]．中国实验血液学杂志，2014，22(3)：595-599.
|
| [36] |
Nakano M, Nagaishi K, Konari N, et a1.Bone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by exosome transfer into damaged neurons and astrocytes[J]. Sci Rep, 2016，6：24805.
|